Search is Powered by Google
Urology / Nephrology News

Radical Nephrectomy Is Not Superior To Nephron-Sparing Surgery In PT1b-pT2N0M0 Renal Tumors

Main Category: Urology / Nephrology
Also Included In: Cancer / Oncology;  Clinical Trials / Drug Trials
Article Date: 06 Apr 2008 - 0:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:5 stars

5 (1 votes)

Health Professional:4 and a half stars

4.5 (2 votes)

Article Opinions: 0 posts

UroToday.com - Dr. Patard from Rennes, France presented on behalf of a large international group regarding partial nephrectomy (PN) and radical nephrectomy (RN) in the setting of organ confined tumor measuring more than 4 cm.

Out of a multi-institutional database including 2,406 PN procedures, 289 which were performed for pT1b-pT2N0M0 renal tumors were selected for comparison with a matched radical nephrectomy group. For that purpose, out of 1,507 renal tumors operated by radical nephrectomy (RN) and having identical TNM stage, 257 were selected after matching with the PN group for tumor size and Fuhrman grade.

Five hundred and forty six renal procedures were included in this retrospective study. During a mean follow-up of 54 months, only 36 (6.6%) patients died from cancer. The PN (n=289) and the RN groups (n=257), were comparable for age at diagnosis (59.3 vs. 61), tumor size (5.47vs. 5.5 cm), T stage (T1, 273(94.5%) vs. 241(93.8%)) and Fuhrman grade (G1-G2, 234(81%) vs. 204(79.4%)). When comparing cancer specific survival between the 2 groups, survival curves perfectly overlapped. Regarding predictive parameters, the authors found survival, T stage, Fuhrman grade and age at diagnosis significant in univariate analysis while T stage and age remained independent prognostic parameters in multivariate analysis. Surgical approach, in this selected low risk population had absolutely no impact on outcome either in uni- or in multi-variate analysis.

Presented by: J.J. Patard, MD, at the European Association of Urology - 23rd Annual EAU Congress - March 26 - 29, 2008 - Milan, Italy

Reported by UroToday.com Contributing Editor, Christopher P. Evans, MD

UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice.

To access the latest urology news releases from UroToday, go to: www.urotoday.com

Copyright © 2008 - UroToday

Ad Banner - the most access to the best resources


Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Psychiatry Urology
Bipolar

Sign up to receive newsletters / news alerts
MedReader RSS Reader


Hormonal Therapy: Prostate image Hormonal Therapy: Prostate

Prostate cancer is the second leading cancer killer of men in the U.S. Among the treatment options for this disease are surgery, radiation therapy and hormonal therapy, which limits the effects of male hormones on growing cancer cells. Find out how hormonal therapy is being used to fight prostate...

Yeast Infections Introduction image Yeast Infections Introduction

When women experience the signs of a yeast infection, they often prefer to self-medicate rather than check with their doctor. But the symptoms are similar to those of more serious conditions and only your doctor can tell the difference. Tune is as our experts share important information all women...

View more videos...